Effect of 4-Quinolone Antibiotics on Cell Function, Cell Growth, and Pyrimidine Nucleotide Biosynthesis in Human Lymphocytes In Vitro

  • A. Forsgren
Conference paper


The new 4-quinolones such as ciprofloxacin, norfloxacin, and ofloxacin are strongly bactericidal, with activities approaching 1000 times that of nalidixic acid [12]. They are effective against a wider range of bacteria, including Pseudomonas aeruginosa and gram-positive cocci, which are considered resistant to nalidixic acid [6]. The activity of this family of drugs may be due to inhibition of bacterial DNA synthesis [5, 12]. Due to the great potential for the clinical use of these drugs it is important to investigate any possible positive or negative side effects on the host defense system.


Human Lymphocyte Nalidixic Acid Antimicrob Agent Thymidine Incorporation Salvage Pathway 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bensussan A, Meurer SC, Schlossman SF, Reinherz EL (1984) Delineation of an immunoregulatory amplifier population recognizing autologous la molecules. J Exp Med 159:559– 576PubMedCrossRefGoogle Scholar
  2. 2.
    Boyum A (1968) Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest [Suppl]97:77Google Scholar
  3. 3.
    Crissman HA, Steinkamp JA (1973) Rapid simultaneous measurement of DNA, protein, and cell volume in single cells from large mammalian cell populations. J Cell Biol 59:766–771PubMedCrossRefGoogle Scholar
  4. 4.
    Darzynkiewicz Z, Crissman H, Traganos F, Steinkamp J (1982) Cell heterogeneity during the cell cycle. J Cell Physiol 113:465–474PubMedCrossRefGoogle Scholar
  5. 5.
    Drlica K (1984) Biology of bacterial dexyribonucleic acid topoisomerases. Microbiol Rev 48:273–289PubMedGoogle Scholar
  6. 6.
    Forsgren A (1985) Comparative in vitro activity of three new quinolone antibiotics against recent clinical isolates. Scand J Infect Dis 17:91–94PubMedCrossRefGoogle Scholar
  7. 7.
    Forsgren A, Bergkvist PI (1985) Effect of ciprofloxacin on phagocytosis. Eur J Clin Microbiol 4:575–578PubMedCrossRefGoogle Scholar
  8. 8.
    Forsgren A, Bergh AK, Brandt M, Hansson G (1986) Quinolones affect thymidine incorporation into the DNA of human lymphocytes. Antimicrob Agents Chemother 29:506–508PubMedGoogle Scholar
  9. 9.
    Forsgren A, Bredberg A, Pardee AB, Schlossman SF, Tedder TF (1987) Effects of ciprofloxacin on encaryotic pyrimidine nucleotide biosynthesis and cell growth. Antimicrob Agents Chemother 31:774–779PubMedGoogle Scholar
  10. 10.
    Forsgren A, Schlossman SF, Tedder TFT (1987) 4-Quinolone drugs affect cell cycle progression and function of human lymphocytes in vitro. Antimicrob Agents Chemother 31:768–773PubMedGoogle Scholar
  11. 11.
    Gollapudi SVS, Prabhala RH, Thadepalli H (1986) Effect of ciprofloxacin on mitogen-stim-ulated lymphocyte proliferation. Antimicrob Agents Chemother 29:337–338PubMedGoogle Scholar
  12. 12.
    Smith JT (1984) Awakening the slumbering potential of the 4-quinolone antibacterials. Pharm J 15:209–305Google Scholar
  13. 13.
    Tedder TF, Boyd AW, Freedman AS, Nadler LM, Schlossman SF (1985) The B cell surface molecule B1 is functionally linked with B cell activation and differentiation. J Immunol 135:973–979PubMedGoogle Scholar
  14. 14.
    Swyryd EA, Seaver SS, Stark GR (1974) N-(Phosphoracetyl)-L-aspartate, a potent transition state analog inhibitor of aspartate transcarbamylase, blocks proliferation of mammalian cells in culture. J Biol Chem 249:6945–6950PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • A. Forsgren
    • 1
  1. 1.Department of Medical Microbiology, Malmö General HospitalUniversity of LundMalmöSweden

Personalised recommendations